Clinical Trials Directory

Trials / Completed

CompletedNCT06032481

System to Evaluate the Risk of Lymph Node Metastasis Preoperatively in Cervical Cancer

Preoperative Scoring System to Predict the Risk of Lymph Node Metastasis in Cervical Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
426 (actual)
Sponsor
Fujian Maternity and Child Health Hospital · Academic / Other
Sex
Female
Age
25 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.

Detailed description

Lymph nodes metastasis (LNM) was proved to be a critical risk factor related to the survival to cervical cancer survival. However, preoperative pelvic magnetic resonance imaging (MR) or computed tomography (CT) tests are less sensitive to assess the risk of lymph node metastasis. PET-CT is too expensive and radiative to be widely used in clinical practice. A model was constructed based on clinical indicators to predict lymph node metastasis preoperatively, providing a reference for clinical treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgeryPatients confirmed cervical cancer were undergone radical hysterectomy with pelvic lymphadenectomy

Timeline

Start date
2012-01-01
Primary completion
2019-12-01
Completion
2023-03-15
First posted
2023-09-13
Last updated
2023-09-13

Source: ClinicalTrials.gov record NCT06032481. Inclusion in this directory is not an endorsement.